Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11998)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 21, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fujita K, Iwama H, Miyoshi H, Tani J, Oura K, Tadokoro T, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Masaki T. Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol 2016; 22(27): 6100-6113 [PMID: 27468203 DOI: 10.3748/wjg.v22.i27.6100] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i27/6100.htm |
| Number | Citing Articles |
| 1 |
Xieyi Zhang, Takuo Ogihara, Min Zhu, Dolgormaa Gantumur, Yang Li, Kenta Mizoi, Hiroki Kamioka, Yoshito Tsushima. Effect of metformin on18F-fluorodeoxyglucose uptake and positron emission tomographic imaging. The British Journal of Radiology 2022; 95(1130) doi: 10.1259/bjr.20200810
|
| 2 |
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
|
| 3 |
Tingting Shi, Hideki Kobara, Kyoko Oura, Tsutomu Masaki. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. Journal of Hepatocellular Carcinoma 2021; : 45 doi: 10.2147/JHC.S274933
|
| 4 |
Shu-Ling Chen, Chia-Ying Ho, Wei-Chun Lin, Chao-Wei Lee, Yu-Chun Chen, Jiun-Liang Chen, Hsing-Yu Chen. The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs. International Journal of Environmental Research and Public Health 2022; 19(19): 12480 doi: 10.3390/ijerph191912480
|
| 5 |
Ke Shi, Jie Hou, Qun Zhang, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1127913
|
| 6 |
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, Nikolaos Machairas. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?. Cancers 2023; 15(12): 3161 doi: 10.3390/cancers15123161
|
| 7 |
Yoshio Sumida, Yuya Seko, Masashi Yoneda. Novel antidiabetic medications for non‐alcoholic fatty liver disease with type 2 diabetes mellitus. Hepatology Research 2017; 47(4): 266 doi: 10.1111/hepr.12856
|
| 8 |
Hsin-Hwa Tsai, Hong-Yue Lai, Yueh-Chiu Chen, Chien-Feng Li, Huei-Sheng Huang, Hsiao-Sheng Liu, Yau-Sheng Tsai, Ju-Ming Wang. Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway. Oncotarget 2017; 8(8): 13832 doi: 10.18632/oncotarget.14640
|
| 9 |
Victor Cunha, Helma Pinchemel Cotrim, Raquel Rocha, Kellyane Carvalho, Liliane Lins-Kusterer. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review. Annals of Hepatology 2020; 19(3): 232 doi: 10.1016/j.aohep.2019.10.005
|
| 10 |
Ameer Abutaleb, Jose Antonio Almario, Saleh Alghsoon, Ji Ae Yoon, Kate Gheysens, Shyam Kottilil, Eleanor Wilson. Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers. Journal of Clinical and Experimental Hepatology 2021; 11(2): 195 doi: 10.1016/j.jceh.2020.08.001
|
| 11 |
AchalGaniga Lingaraj, Shisheer Havangi, AnishBandalore Satheesha, Arjun Naidu, Ketan Garg, Bhawna Garg. Metformin use and Occurrence of Hepatocellular Carcinoma in Patients with Type II Diabetes Mellitus: A Systematic Review. Journal of Radiation and Cancer Research 2023; 0(0): 0 doi: 10.4103/jrcr.jrcr_65_22
|
| 12 |
Sabina Di Matteo, Lorenzo Nevi, Diletta Overi, Nadine Landolina, Jessica Faccioli, Federico Giulitti, Chiara Napoletano, Andrea Oddi, Augusto M. Marziani, Daniele Costantini, Agostino M. De Rose, Fabio Melandro, Maria C. Bragazzi, Gian Luca Grazi, Pasquale B. Berloco, Felice Giuliante, Giuseppe Donato, Lorenzo Moretta, Guido Carpino, Vincenzo Cardinale, Eugenio Gaudio, Domenico Alvaro. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81172-0
|
| 13 |
Khatimya Kudabayeva, Raikul Kosmuratova, Yerlan Bazargaliyev, Aigul Sartayeva, Nurgul Kereyeva. Effects of metformin on lymphocyte DNA damage in obese individuals among Kazakh population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(8): 102569 doi: 10.1016/j.dsx.2022.102569
|
| 14 |
Catherine Mezzacappa, Nadim Mahmud, Marina Serper, Binu V. John, Tamar H. Taddei, David E. Kaplan. HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis. Hepatology Communications 2023; 7(12) doi: 10.1097/HC9.0000000000000344
|
| 15 |
Taiga Chiyo, Kiyohito Kato, Hisakazu Iwama, Shintaro Fujihara, Koji Fujita, Tomoko Tadokoro, Kyoko Ohura, Eri Samukawa, Yoshimi Yamana, Nobuya Kobayashi, Tae Matsunaga, Noriko Nishiyama, Maki Ayaki, Tatsuo Yachida, Asahiro Morishita, Hideki Kobara, Hirohito Mori, Tsutomu Masaki. Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma. International Journal of Oncology 2017; 50(6): 2145 doi: 10.3892/ijo.2017.3971
|
| 16 |
Tomoko Tadokoro, Asahiro Morishita, Takashi Himoto, Tsutomu Masaki. Nutritional Support for Alcoholic Liver Disease. Nutrients 2023; 15(6): 1360 doi: 10.3390/nu15061360
|
| 17 |
Han Cui, XiuWei Zhang. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review. Journal of Pediatric Endocrinology and Metabolism 2020; 33(5): 579 doi: 10.1515/jpem-2019-0595
|
| 18 |
Emilie Crouchet, Catherine Schuster, Thomas F. Baumert. Liver cell circuits and therapeutic discovery for advanced liver disease and cancer. Comptes Rendus. Biologies 2021; 344(3): 233 doi: 10.5802/crbiol.64
|
| 19 |
Moustafa Nouh Elemeery, Marwa Anwar Mohamed, Marwa Ahmed Madkour, Mohammed Mohammed Shamseya, Noha Mahmoud Issa, Ahmed Noah Badr, Doaa Ahmed Ghareeb, Cheol-Ho Pan. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World Journal of Gastroenterology 2019; 25(42): 6322-6341 doi: 10.3748/wjg.v25.i42.6322
|
| 20 |
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00125
|
| 21 |
Zongqiang Hu, Yingpeng Zhao, Laibang Li, Jie Jiang, Wang Li, Yuanyi Mang, Yang Gao, Yun Dong, Jiashun Zhu, Chaomin Yang, Jianghua Ran, Li Li, Shengning Zhang. Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3. Molecular Biology Reports 2023; 50(8): 6399 doi: 10.1007/s11033-023-08492-4
|
| 22 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
| 23 |
Rashmi R. Shah, Peter D. Stonier. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead. Journal of Clinical Pharmacy and Therapeutics 2019; 44(1): 6 doi: 10.1111/jcpt.12759
|
| 24 |
Stuart C. Gordon, Humberto C. Gonzalez. Schiff's Diseases of the Liver. 2017; : 218 doi: 10.1002/9781119251316.ch8
|
| 25 |
Rong‐Xing Liu, Yan Ma, Xue‐Lian Hu, Yun‐Peng Liao, Xiang‐Nan Hu, Bai‐Cheng He, Wen‐Juan Sun. Pioglitazone/metformin adduct regulates insulin secretion and inhibits high glucose‐induced apoptosis via p21‐p53‐MDM2 signaling in INS‐1 cells. Journal of Cellular Biochemistry 2018; 119(7): 5449 doi: 10.1002/jcb.26701
|
| 26 |
A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya. Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(2): 14 doi: 10.22416/1382-4376-2021-31-2-14-26
|
| 27 |
Mark Williams, Xinhui Liu, Yueqi Zhang, Jake Reske, Devika Bahal, Trevor G. Gohl, Daniel Hollern, Elliot Ensink, Matti Kiupel, Rongcheng Luo, Rupali Das, Hua Xiao. NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin. Oncogene 2020; 39(19): 3821 doi: 10.1038/s41388-020-1256-x
|
| 28 |
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma. Research Journal of Pharmacy and Technology 2023; : 377 doi: 10.52711/0974-360X.2023.00065
|
| 29 |
Laura Mazilu, Dana Stanculeanu, Andreea Gheorghe, Adrian-Paul Suceveanu, Irinel Parepa, Felix Voinea, Doina Catrinoiu, Andra-Iulia Suceveanu. Metformin [Working Title]. 2019; doi: 10.5772/intechopen.88803
|
| 30 |
Xinhui Liu, Feiye Liu, Shenglan Gao, Jake Reske, Aimin Li, Chin-Lee Wu, Chengfeng Yang, Fengsheng Chen, Rongcheng Luo, Hua Xiao. A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation. Cancer Letters 2017; 391: 152 doi: 10.1016/j.canlet.2017.01.028
|
| 31 |
Qingyun Zhang, Jian Kong, Shuying Dong, Wenlei Xu, Wenbing Sun. Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0418-6
|
| 32 |
Satoko Umetsu, Hiroki Mizukami, Takeshi Saito, Chiaki Uchida, Akiko Igawa, Kazuhiro Kudo, Chieko Itabashi, Sho Osonoi, Guo Danyang, Takanori Sasaki, Soroku Yagihashi, Kenichi Hakamada. Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57883-1
|
| 33 |
Masoud Najafi, Mohsen Cheki, Saeed Rezapoor, Ghazale Geraily, Elahe Motevaseli, Carla Carnovale, Emilio Clementi, Alireza Shirazi. Metformin: Prevention of genomic instability and cancer: A review. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2018; 827: 1 doi: 10.1016/j.mrgentox.2018.01.007
|
| 34 |
Andrea Casadei-Gardini, Roberto Filippi, Margherita Rimini, Ilario Giovanni Rapposelli, Lorenzo Fornaro, Nicola Silvestris, Luca Aldrighetti, Giacomo Aimar, Giulia Rovesti, Giulia Bartolini, Caterina Vivaldi, Oronzo Brunetti, Elisa Sperti, Rosa La Face, Francesca Ratti, Kalliopi Andrikou, Martina Valgiusti, Laura Bernardini, Antonella Argentiero, Elisabetta Fenocchio, Giovanni Luca Frassineti, Silvia Cesario, Francesco Giovannelli, Virginia Quarà, Francesco Leone, Stefano Cascinu. Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients. Oncology 2021; 99(5): 292 doi: 10.1159/000512796
|
| 35 |
Chien-Yu Lin, Pratik Adhikary, Kun Cheng. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Advanced Drug Delivery Reviews 2021; 174: 127 doi: 10.1016/j.addr.2021.04.008
|
| 36 |
Bhrigu Kumar Das, Pramod C Gadad. Impact of diabetes on the increased risk of hepatic cancer: An updated review of biological aspects. Diabetes Epidemiology and Management 2021; 4: 100025 doi: 10.1016/j.deman.2021.100025
|
| 37 |
Wei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin, Kuang-Den Chen, Ching-Hui Chuang, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai, Ming-Lung Yu. Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients. PLOS ONE 2021; 16(3): e0247231 doi: 10.1371/journal.pone.0247231
|
| 38 |
Guang-Ying Shi, Yu Sun, Xing-Chen Liang, Jing-Dong Xie. Clinical significance of expression of serum insulin-like growth factor-1 in patients with primary liver cancer and diabetes mellitus. World Chinese Journal of Digestology 2021; 29(5): 236 doi: 10.11569/wcjd.v29.i5.236
|
| 39 |
Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Diabetes & Metabolism Journal 2020; 44(3): 382 doi: 10.4093/dmj.2020.0010
|
| 40 |
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, Emily Corbould, Jeffrey V. Lazarus, Laura Webber, Nick Sheron. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. Journal of Hepatology 2018; 69(3): 718 doi: 10.1016/j.jhep.2018.05.011
|
| 41 |
Xu Li, Xiaocong Wang, Pujun Gao. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5202684
|
| 42 |
Maja Cigrovski Berkovic, Francesco Giovanardi, Anna Mrzljak, Quirino Lai. Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis. World Journal of Diabetes 2023; 14(8): 1289-1300 doi: 10.4239/wjd.v14.i8.1289
Abstract(352) |
Core Tip(179) |
Full Article(HTML)(943)
|
Full Article with Cover (PDF)-3646K(44)
|
Full Article (Word)-1039K(21)
|
Audio-11949K(0)
|
Peer-Review Report-253K(32)
|
Answering Reviewers-78K(20)
|
Full Article (PDF)-3456K(129)
|
Full Article (XML)-147K(18)
|
Times Cited (0)
|
Total Visits (3129)
|
Open
|
| 43 |
Tomasz Szkudelski, Klaudia Konieczna, Katarzyna Szkudelska. Regulatory Effects of Metformin, an Antidiabetic Biguanide Drug, on the Metabolism of Primary Rat Adipocytes. Molecules 2022; 27(16): 5250 doi: 10.3390/molecules27165250
|
| 44 |
Carlo B. Giorda, Roberta Picariello, Barbara Tartaglino, Elisa Nada, Giuseppe Costa, Roberta Manti, Luca Monge, Roberto Gnavi. Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. Diabetes Research and Clinical Practice 2023; 200: 110684 doi: 10.1016/j.diabres.2023.110684
|
| 45 |
Sadia Nazer, Saiqa Andleeb, Shaukat Ali, Nazia Gulzar, Abida Raza, Habib Khan, Kalsoom Akhtar, Muhammad Naeem Ahmed. Cytotoxicity, Anti-diabetic, and Hepato-protective Potential of Ajuga
bracteosa-conjugated Silver Nanoparticles in Balb/c Mice. Current Pharmaceutical Biotechnology 2022; 23(3): 318 doi: 10.2174/1389201022666210421101837
|
| 46 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
|
| 47 |
Minoru Ono, Koji Sawada, Toshikatsu Okumura. A case of liver hemangioma with markedly reduced tumor size after metformin treatment: a case report. Clinical Journal of Gastroenterology 2017; 10(1): 63 doi: 10.1007/s12328-016-0705-0
|
| 48 |
Amr Ahmed EL-Arabey. New insight for metformin against bladder cancer. Genes and Environment 2017; 39(1) doi: 10.1186/s41021-017-0074-z
|
| 49 |
Koji Fujita, Asahiro Morishita, Kyoko Oura, Masafumi Ono, Takashi Himoto, Tsutomu Masaki. Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-50778-x
|
| 50 |
Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Lilian Yan Liang, Vicki Wing-Ki Hui, Vincent Wai-Sun Wong, Grace Lai-Hung Wong. Risk of HCC in Patients with HBV, Role of Antiviral Treatment. Current Hepatology Reports 2022; 21(4): 76 doi: 10.1007/s11901-022-00588-y
|
| 51 |
Adriana Mercan-Stanciu, Teodora Isac, Razvan Rababoc, Daniel Rusie, Letitia Toma, Ileana Adela Vacaroiu, Raluca Tulin, Elena Laura Iliescu. Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals. Cureus 2022; doi: 10.7759/cureus.25487
|
| 52 |
|